Metraipolis › archive › dc_47f572fe65ce

Pharmacogenomic Stratification for Oncology Drug Repurposing: An Exposure Target Context Eligibility Framework — Europe PMC PMID:42356574

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42356574
DOI
10.3390/ph19060957
License (as archived)
solo-consultazione
Archived
2026-10-19T08:00:12.940Z
SHA-256 of the archived text
fd8fc1e550fae051f87b3acb22ca0eff5e0740bdb8f4789d306e0ab2aae9aecd
Stable URL of this page
https://metraipolis.com/documento/dc_47f572fe65ce

How to cite

Pharmacogenomic Stratification for Oncology Drug Repurposing: An Exposure Target Context Eligibility Framework — Europe PMC PMID:42356574 — Europe PMC (en), https://europepmc.org/article/MED/42356574 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_47f572fe65ce (Metraipolis archive dc_47f572fe65ce, sha256 fd8fc1e550fae051f87b3acb22ca0eff5e0740bdb8f4789d306e0ab2aae9aecd)
BibTeX
@misc{dc47f572fe65ce,
  title = {Pharmacogenomic Stratification for Oncology Drug Repurposing: An Exposure Target Context Eligibility Framework — Europe PMC PMID:42356574},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42356574},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_47f572fe65ce; sha256 fd8fc1e550fae051f87b3acb22ca0eff5e0740bdb8f4789d306e0ab2aae9aecd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42356574. Agents can read the archived copy with the MCP tool read_document.